Skip to main content
. Author manuscript; available in PMC: 2014 Jun 10.
Published in final edited form as: Exp Cell Res. 2013 Mar 19;319(10):1431–1442. doi: 10.1016/j.yexcr.2013.02.017

Figure 1. MOSE cancer cell progression results in a glycolytic phenotype.

Figure 1

Cells were incubated in serum-free medium for 2h, the appropriate substrates added and changes in (A) glucose oxidation at 3 h, (B) fatty acid oxidation at 3 h, (C) lactate secretion at 8 h and (D) glucose uptake at 10 min in early (MOSE-E) intermediate (MOSE-I) and late (MOSE-L) stages of ovarian cancer were measured as described under methods. Data are presented as mean ± SEM. Different from MOSE-E, *p 0.01, **p 0.001.